A genetic screen identifies an LKB1–MARK signalling axis controlling the Hippo–YAP pathway

Cited by (290)

Items 201–290 of 290

  1. KRAS-mutant non-small cell lung cancer (NSCLC) therapy based on tepotinib and omeprazole combination
    Rafael Rosell, Eloisa Jantus Lewintre, Peng Cao, Xueting Cai, B. Xing, Masaoki Ito, Jose Luis Gomez-Vazquez, Mireia Marco-Jordán, Silvia Calabuig Fariñas, Andrés Felipe Cardona et al. · 2024 · Cell Communication and Signaling
  2. Regulation of the Hippo signaling pathway by deubiquitinating enzymes in cancer
    Ashley L. Mussell, Costa G. Frangou, Jianmin Zhang · 2019 · Genes & Diseases
  3. Targeting YAP/TAZ–TEAD and their protein-protein interaction for precision cancer therapy
    Fangyuan Chen, Jinxuan Su, Yongqi Liu, Zhijing Zhang, Sijia Li, Yonggang Yuan, Jianqin Lai · 2025 · European Journal of Medicinal Chemistry
  4. Targeting YAP/TAZ in Combination with PD-L1 Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer (NSCLC)
    Kostas A. Papavassiliou, Georgios Marinos, Athanasios G. Papavassiliou · 2023 · Cells
  5. The Dimeric Form of HPV16 E6 Is Crucial to Drive YAP/TAZ Upregulation through the Targeting of hScrib
    Lorenzo Messa, Marta Celegato, Chiara Bertagnin, Beatrice Mercorelli, Gualtiero Alvisi, Lawrence Banks, Giorgio Palù, Arianna Loregian · 2021 · Cancers
  6. YAP and TAZ Regulate Cc2d1b and Purβ in Schwann Cells
    Sophie Belin, Jacob Herron, Jordan J. S. VerPlank, Yungki Park, Laura M. Feltri, Yannick Poitelon · 2019 · Frontiers in Molecular Neuroscience
  7. Clinical potential of the Hippo-YAP pathway in bladder cancer
    Xin Cheng, Kecheng Lou, Liang Ding, Xiaofeng Zou, Ruohui Huang, Gang Xu, Junrong Zou, Guoxi Zhang · 2022 · Frontiers in Oncology
  8. Low Expression of CAPON in Glioma Contributes to Cell Proliferation via the Akt Signaling Pathway
    Shangfeng Gao, Jie Wang, Tong Zhang, Guangping Liu, Lei Jin, Daofei Ji, Peng Wang, Qingming Meng, Yufu Zhu, Rutong Yu · 2016 · International Journal of Molecular Sciences
  9. The Physiological Function of nNOS-Associated CAPON Proteins and the Roles of CAPON in Diseases
    Wenshuo Xie, Nianhong Xing, Jicheng Qu, Dongwu Liu, Qiuxiang Pang · 2023 · International Journal of Molecular Sciences
  10. MARK2 inhibits the growth of HeLa cells through AMPK and reverses epithelial-mesenchymal transition
    Ge Xu, Yinggang Ge, Xiaohong Tao, Qing Gao, Xiaoyan Liang · 2017 · Oncology Reports
  11. Stearoylation cycle regulates the cell surface distribution of the PCP protein Vangl2
    Jiafu Ying, Yinghong Yang, Xuanpu Zhang, Ze Dong, Baoen Chen · 2024 · Proceedings of the National Academy of Sciences
  12. Mark1 regulates distal airspace expansion through type I pneumocyte flattening in lung development
    Katsumi Fumoto, Hisako Takigawa-Imamura, Kenta Sumiyama, Shige H. Yoshimura, Natsumi Maehara, Akira Kikuchi · 2019 · Journal of Cell Science
  13. Need for multi-scale systems to identify spindle orientation regulators relevant to tissue disorganization in solid cancers
    Hui Men Selina Chin, Karandeep Nandra, Joanna Clark, Viji M. Draviam · 2014 · Frontiers in Physiology
  14. EXPLICIT‐Kinase: A gene expression predictor for dissecting the functions of the Arabidopsis kinome
    Yuming Peng, Wanzhu Zuo, Hui Zhou, Fenfen Miao, Yu Zhang, Yue Qin, Yi Liu, Yu Long, Shisong Ma · 2022 · Journal of Integrative Plant Biology
  15. Phosphorylation analysis of the Hippo-YAP pathway using Phos-tag
    Cho-Long Kim, Subin Lim, Kyeongseob Kim, Han-Sol Jeong, Jung‐Soon Mo · 2022 · Journal of Proteomics
  16. Is 5´-AMP-Activated Protein Kinase Both Jekyll and Hyde in Bladder Cancer?
    Wun‐Jae Kim · 2015 · International Neurourology Journal
  17. New insights in Hippo signalling alteration in human papillomavirus-related cancers
    Leslie Olmedo‐Nieva, J. Omar Muñoz-Bello, Joaquín Manzo-Merino, Marcela Lizano · 2020 · Cellular Signalling
  18. Genome-wide CRISPR screens in spheroid culture reveal that the tumor suppressor LKB1 inhibits growth via the PIKFYVE lipid kinase
    John R. Ferrarone, Jerin Thomas, Arun M. Unni, Yuxiang Zheng, Michal J. Nagiec, Eric E. Gardner, Oksana Mashadova, Kate Li, Nikos Koundouros, Antonino Montalbano et al. · 2024 · Proceedings of the National Academy of Sciences
  19. Luciferase Reporter Assays to Determine YAP/TAZ Activity in Mammalian Cells
    Sirio Dupont · 2018 · Methods in molecular biology
  20. Erdr1 Drives Macrophage Programming via Dynamic Interplay with YAP1 and Mid1
    Yuhang Wang · 2024 · ImmunoHorizons
  21. Yorkie drives Ras-induced tumor progression by microRNA-mediated inhibition of cellular senescence
    Takao Ito, Tatsushi Igaki · 2021 · Science Signaling
  22. PTEN and LKB1 are differentially required in Gli1-expressing mesenchymal cells to suppress gastrointestinal polyposis
    Jennifer L. Cotton, Kyvan Dang, Lu Hu, Yang Sun, Alka Singh, Mihir Rajurkar, Qi Li, Xu Wu, Junhao Mao · 2022 · Cell Reports
  23. Kinome profiling identifies MARK3 and STK10 as potential therapeutic targets in uveal melanoma
    Usman Baqai, Alison Kurimchak, Isabella V. Trachtenberg, Timothy J. Purwin, Jelan I. Haj, Anna Han, Kristine Luo, Nikole Fandiño Pachon, Angela Jeon, Vivian Y.L. Chua et al. · 2023 · Journal of Biological Chemistry
  24. Non-hippo kinases: indispensable roles in YAP/TAZ signaling and implications in cancer therapy
    Jun Zhu, Tiantian Wu, Qiong Lin · 2023 · Molecular Biology Reports
  25. New Horizons in Cancer Progression and Metastasis: Hippo Signaling Pathway
    Murali R. Kuracha, Uppala Radhakrishna, Sreenaga V. Kuracha, Navyasri Vegi, Jhyama Lhamo Gurung, Benita L. McVicker · 2024 · Biomedicines
  26. Integrating Genetic Alterations and the Hippo Pathway in Head and Neck Squamous Cell Carcinoma for Future Precision Medicine
    Toshinori Ando, Kento Okamoto, Tomoaki Shintani, Souichi Yanamoto, Mutsumi Miyauchi, Jorge Silvio Gutkind, Mikihito Kajiya · 2022 · Journal of Personalized Medicine
  27. RhoBTB Proteins Regulate the Hippo Pathway by Antagonizing Ubiquitination of LKB1
    Thanh Nguyen, Adela Ralbovska, Jan‐Michael Kugler · 2020 · G3 Genes Genomes Genetics
  28. Polarity Determinants in Dendritic Spine Development and Plasticity
    Huaye Zhang · 2015 · Neural Plasticity
  29. TEAD transcription factor family emerges as a promising therapeutic target for oral squamous cell carcinoma
    Shuang Wang, Dan Shao, Xiaoyan Gao, Peng Zhao, Fanzhi Kong, Jiawei Deng, Lianzhu Yang, Wei Shang, Yaping Sun, Zhiguang Fu · 2024 · Frontiers in Immunology
  30. Intestinal LKB1 Loss Drives a Premalignant Program Along the Serrated Cancer Pathway
    Susanna Plugge, H. Ma, Jelte van der Vaart, Joep Sprangers, Folkert H.M. Morsink, Despina Xanthakis, C. Jamieson, K B W Stroot, A. Keijzer, Thanasis Margaritis et al. · 2025 · Gastroenterology
  31. Recent Hints on the Dual Role of Discs Large MAGUK Scaffold Protein 5 in Cancers and in Hepatocellular Carcinoma
    Chiara Andolfi, Claudio Tiribelli, Devis Pascut · 2022 · Frontiers in Bioscience-Landmark
  32. Structure of the complex of phosphorylated liver kinase B1 and 14-3-3ζ
    Yongjian Lu, Sheng Li Ding, Ruiqing Zhou, Jianyong Wu · 2017 · Acta Crystallographica Section F Structural Biology Communications
  33. Erratum: Corrigendum: A genetic screen identies an LKB1–MARK signalling axis controlling the Hippo–YAP pathway
    Morvarid Mohseni, Jianlong Sun, Allison N. Lau, Stephen J. Curtis, Jeffrey D. Goldsmith, Victor L. Fox, Chongjuan Wei, Marsha L. Frazier, Owen J Samson, Kwok‐Kin Wong et al. · 2014 · Nature Cell Biology
  34. Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis
    Camino Bermejo‐Rodríguez, Joaquín Araos Henríquez, Giuseppina Caligiuri, Sara Pinto Teles, Youngkyu Park, Anthony Evans, Lawrence N. Barrera, Albrecht Neeße, Robert Grützmann, Daniela Ellen Aust et al. · 2024 · Cancer Research
  35. KANK1 promotes breast cancer development by compromising Scribble-mediated Hippo activation
    Shiny Shengzhen Guo, Zhiying Liu, Guan Wang, Zhiqi Sun, Kaikai Yu, James P. Fawcett, Reinhard Büttner, Bo Gao, Reinhard Faessler · 2024 · Nature Communications
  36. Methods to assess small molecule allosteric modulators of the STRAD pseudokinase
    Tingting Qing, Jin Liu, Fen Liu, Dom C. Mitchell, Richard T. Beresis, John Dozier Gordan · 2022 · Methods in enzymology on CD-ROM/Methods in enzymology
  37. Connections between cadherin-catenin proteins, spindle misorientation, and cancer
    Marta N. Shahbazi, Mirna Pérez‐Moreno · 2015 · Tissue Barriers
  38. Targeting the Hippo Pathway to Improve Response to Chemotherapy
    Yulei Zhao, Xiaolong Yang · 2018 · Elsevier eBooks
  39. Breast cancer drug resistance: Decoding the roles of Hippo pathway crosstalk
    Fariba Dehghanian, Laleh Ebrahimi Ghahnavieh, Amirhossein Naghsh Nilchi, Sheyda Khalilian, Rezvan Joonbakhsh · 2024 · Gene
  40. Molecular Bases for Combinatorial Treatment Strategies in Patients with KRAS Mutant Lung Adenocarcinoma and Squamous Cell Lung Carcinoma
    Chiara Lazzari, Alberto Verlicchi, Αναστάσιος Γκουντάκος, Sara Pilotto, Mariacarmela Santarpía, Imane CHAIB-OUKADOUR, José Luis Ramírez, Santiago Viteri, Daniela Morales-Espinosa, Claudio Dazzi et al. · 2016 · Pulmonary Therapy
  41. MicroRNA-135b as therapeutic target in cancers
    2015 · RNA & DISEASE
  42. The role of Capon in multiple myeloma
    Yaodong Shen, Haiyan Liu, Siyu Gu, Ziwei Wei, Hong Liu · 2017 · Tumor Biology
  43. Small-molecule activation of the tumor suppressor kinase LKB1 via the pseudokinase STRAD
    Lin Song, Dominique C. Mitchell, Jin Liu, Logan B. Leak, Rigney E. Turnham, LeeAnn Wang, Zheng Wang, Changliang He, Luo Ding, Marc Adler et al. · 2026 · Cell chemical biology
  44. [Role of Hippo Signaling Pathway in Lung Cancer].
    Yuechao Liu, Ying Xing, Li Cai · 2017 · Europe PMC (PubMed Central)
  45. The role of the neural NO synthase adapter protein in the pathogenesis of metabolic syndrome and type 2 diabetes mellitus
    Ludmila A. Kuznetsova, Nataliia E. Basova · 2023 · Сибирский научный медицинский журнал
  46. Tumor suppressor genes and KRAS G12C inhibitor resistance in non-small cell lung cancer
    Linsha Zhu, Xiangbo Jia, Lei Xu, Li Chen, Xiangning Fu, Hua Yan, Bo Ai, Shu Peng · 2025 · iScience
  47. STK11 Mutations and Deletions Define an Aggressive Molecular Subgroup of Cervical Adenocarcinoma
    Emma Robinson, Elisabeth A. Murphy, Anaseidy Albanez, Sonam Tulsyan, Hong Lou, Yi Xie, Weiyin Zhou, Qian Yang, Tawnjerae R. Joe, Tongwu Zhang et al. · 2026 · Cancer Medicine
  48. Navigating the Maze of Kinases: CaMK-like Family Protein Kinases and Their Role in Atherosclerosis
    Jules T. J. Teuwen, Emiel P. C. van der Vorst, Sanne Lidewij Maas · 2024 · International Journal of Molecular Sciences
  49. Section IV: Non–small cell lung cancer and malignant melanoma
    Kevin E. Fisher, Rathi Narayana Pillai, Ragini Reiney Kudchadkar, Michael R. Rossi · 2014 · Current Problems in Cancer
  50. Integrative High-Throughput RNAi Screening Identifies BRSK1, STK32C and STK40 as Novel Activators of YAP/TAZ
    Mandeep K. Gill, Siyuan Song, Tania Y. Christova, Liliana Attisano · 2025 · International Journal of Molecular Sciences
  51. The role of LKB1 in prostate cancer: implications for tumor progression and therapy
    Yuwei Liang, Hongliang Cao, Zhijun Tang, Shuxin Li, Gang Yang, Shuai Dong, Hao Du, Jinguo Wang · 2025 · Frontiers in Cell and Developmental Biology
  52. Molecular insights and therapeutic implications for the tumor suppressor role of LKB1 in non-small cell lung cancer
    Peiqiang Yan, Weiwei Jiang, Xutong Xue, Tao Hou, Jingchao Wang, Daoyuan Huang, Li Chen, Hiroyuki Inuzuka, Xiaoming Dai, Wenyi Wei · 2026 · Cancer Letters
  53. LKB1: Controlling Quiescence and Genomic Integrity at Home
    Carmen Berasain, Matias Antonio Avila · 2018 · Trends in Endocrinology and Metabolism
  54. Verteporfin mitigates sepsis-induced liver injury by blocking macrophage-derived inflammation
    Yaopeng Yang, Anxiu Wang, Su Zhang, Guangming Peng, Wu Haiying · 2022 · Tropical Journal of Pharmaceutical Research
  55. Evaluation of Quantification and Normalization Strategies for Phosphoprotein Phosphatase Affinity Proteomics: Application to Breast Cancer Signaling
    Brooke L. Brauer, Kwame Wiredu, Scott A. Gerber, Arminja Nadine Kettenbach · 2022 · Journal of Proteome Research
  56. Differentiation and Development of the Bovine Blastocyst
    Verónica M. Negrón‐Pérez · 2017 · PhDT
  57. Loss of the endocytic tumor suppressor HD-PTP phenocopies LKB1 and promotes RAS-driven oncogenesis
    Chang-Soo Seong, Chunzi Huang, Austin C. Boese, Yuning Hou, Junghui Koo, Janna K. Mouw, Manali Rupji, Greg Joseph, H. Richard Johnston, Henry Claussen et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  58. Spatiotemporally restricted Hippo signalings instruct the fate and maturation of hepatobiliary cells
    Yebin Wang, Zhenxing Zhong, Yu Wang, Ying Zhu, Kun‐Liang Guan, Fa‐Xing Yu · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  59. Study of the Hippo/YAP1 signaling pathway in gastric carcinogenesis induced by Helicobacter pylori
    Silvia Molina‐Castro · 2017 · theses.fr (ABES)
  60. Novel Posttranslational Modification in LKB1 Activation and Function
    Szu-Wei Lee · 2014 · Digital Commons-TMC (Texas Medical Center)
  61. Heat shock protein 27 inhibits the Hippo tumor suppressor pathway by facilitating MST1 proteasomal degradation
    Sepideh Vahid · 2017 · cIRcle (University of British Columbia)
  62. WITHDRAWN: Regulation of Pyruvate Kinase M Switch towards PKM1 by LKB1-AMPK Axis Tolerates Hypoglycemic Stress in Cancer Cells
    Gopinath Prakasam, Rajnish Kumar Singh, Mohammad Askandar Iqbal, Ashu Bhan Tiku, Ramesh N K Bamezai · 2016 · Journal of Biological Chemistry · Retracted
  63. Characterization of ALDH1A1 as a novel tumorigenic target mediating TAZ-induced lung tumorigenesis and stem cell phenotypes
    Jihang Yu · 2016 · QSpace (Queen's University Library)
  64. Identification and Characterization of Novel Upstream Regulators of the Hippo Signalling Pathway
    Emad Heidaryarash · 2018 · TSpace (University of Toronto)
  65. Hippo signaling pathway regulation of innate immune response
    ChengGang ZOU, Hui Han, YiCheng MA · 2019 · Scientia Sinica Vitae
  66. An integrative resource for investigating genetic model of drug response in cancer
    Yi Guo, Xiang Chen · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  67. SPINT2 Suppresses Hippo Effector YAP and Limits Cellular Tolerance for Aneuploidy
    Huadi Zhang · 2017 · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
  68. Function and Regulation of the α6 Integrins in Mammary Epithelial Biology and Breast Cancer: A Dissertation
    Cheng Chang · 2015 · eScholarship@UMassChan
  69. YAP restricts renal inflammation and mitigates kidney damage in nephronothisis related kidney disease
    Giulia Ferri, Valentine Goffette, Esther Porée, Simone Braeg, Shana Carvalho, Marceau Quatredeniers, E. Wolfgang Kuehn, Sophie Saunier, Amandine Viau · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  70. Faculty Opinions recommendation of Pericyte-like spreading by disseminated cancer cells activates YAP and MRTF for metastatic colonization.
    Andrew C. Dudley · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  71. MAP/Microtubule Affinity-Regulating Kinase
    Elizabeth I. Tang, C. Yan Cheng · 2016 · Springer eBooks
  72. MAP/Microtubule Affinity-Regulating Kinase
    Elizabeth I. Tang, C. Yan Cheng · 2017 · Springer eBooks
  73. Clinicopathological and prognostic significance of LKB1 expression in gastric cancer: a systematic review and meta-analysis
    Guojiang Tan, Baiying Liu · 2023 · Scientific Reports
  74. Scribble Me This: The Basolateral Polarity Complex Regulates Hippo Signaling
    Tobey Colston · 2023 · OSF Preprints (OSF Preprints)
  75. The Role of PDZ in Cerebral Ischemia
    Yeting Chen, Yisi Shan, Wenping Cao, Ye Cao, Jianfeng Pu · 2024 · Modern Chemistry
  76. The ARK side of the cell: Kinases, metabolism, and therapeutic potential in malignancies
    Viviana Coliboro-Dannich, Alejandro Farías, Luis Espinoza-Francine, M Andrea Concha-Vega, Karen Almendras-Durán, Ana María Salazar, Roxana Pincheira, Ariel Fernando Castro · 2025 · Pharmacological Research
  77. Additional file 3 of Activated TAZ induces liver cancer in collaboration with EGFR/HER2 signaling pathways
    Hyuk Moon, Hyunjung Park, Min Jee Chae, Choi, Hye Jin, Kim, Do Young, Simon Weonsang Ro · 2022 · Figshare
  78. Additional file 1 of KRAS-mutant non-small cell lung cancer (NSCLC) therapy based on tepotinib and omeprazole combination
    Rafael Rosell, Eloisa Jantus Lewintre, Cao, Peng, Cai, Xueting, B. Xing, Ito, Masaoki, Jose Luis Gomez-Vazquez, Mireia Marco-Jordán, Silvia Calabuig Fariñas, Cardona, Andrés Felipe et al. · 2024 · Figshare
  79. Additional file 1 of Activated TAZ induces liver cancer in collaboration with EGFR/HER2 signaling pathways
    Hyuk Moon, Hyunjung Park, Min Jee Chae, Choi, Hye Jin, Kim, Do Young, Simon Weonsang Ro · 2022 · Figshare
  80. Additional file 2 of Activated TAZ induces liver cancer in collaboration with EGFR/HER2 signaling pathways
    Hyuk Moon, Hyunjung Park, Min Jee Chae, Choi, Hye Jin, Kim, Do Young, Simon Weonsang Ro · 2022 · Figshare
  81. A novel effect of bevacizumab in reducing characteristic pigmentation in Peutz–Jeghers syndrome: a case report and literature review
    Di Wu, Xinyue Liu, Song Wang, Huanyu Zhang, Guofeng Qu, Lina Wang · 2026 · Frontiers in Oncology
  82. Oral Cancer and Lipids—Bridging the Gap between Health and Disease: A Review
    Dinraj Kulkarni, Sachin Sarode, Sajda Khan Gajdhar, Dhananjay B Ghunawat, Apurva Naik, Gargi Sachin Sarode · 2026 · World Journal of Dentistry
  83. Caractérisation fonctionnelle du complexe LKB1/STRADß au cil primaire et les conséquences au cours de la tumorigenèse
    Pauline Maurin · 2016 · theses.fr (ABES)
  84. The Scrib1 Interactome and its relevance for synaptic plasticity & neurodevelopmental disorders
    Vera Lúcia Margarido Pinheiro · 2014 · theses.fr (ABES)
  85. The Noncanonical Role of Hippo Signaling in Cancer
    Xu Li, Jin Jiang · 2026 · Cold Spring Harbor Perspectives in Biology
  86. Régulation de la voie de signalisation Hippo/YAP/TAZ dans la carcinogenèse gastrique induite par Helicobacter pylori et les propriétés tumorigéniques et invasives des cellules souches cancéreuses
    Camille Tiffon · 2020 · theses.fr (ABES)
  87. Study of Hippo effectors, Yap1 et Wwrt1, during proepicardium formation
    Laia Ortiz López · 2021 · theses.fr (ABES)
  88. Hippo-YAP1 dysregulation as a central driver of therapeutic resistance in cancer: Mechanisms and targeting therapeutic strategies
    Jiahui Zhao, Wanjie Zheng, Yan Zhang, Jinhan He, Hongyu Shan, Baojie Wang, Li Guo, Tingming Liang · 2026 · Critical Reviews in Oncology/Hematology
  89. Greatwall kinase regulates acute myeloid leukaemia cell division through a non-canonical mechanism
    Sandra M. Martín‐Guerrero, Tommy Shields, Pedro Casado, Róbert Zach, Vinothini Rajeeve, Nadia Afroz-Nishat, Irbaz I. Badshah, Megan Meredith, William R. Foster, Helfrid Hochegger et al. · 2026 · EMBO Reports
  90. BindingDB Entry 50015582: Development and Therapeutic Potential of NUAKs Inhibitors.
    BindingDB · 2023 · UC San Diego